Page last updated: 2024-11-01

ofloxacin and Central Nervous System Diseases

ofloxacin has been researched along with Central Nervous System Diseases in 6 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
" Although very useful agents, the fluoroquinolones as a class are associated with a number of adverse events, some with considerable clinical significance."2.46Safety profile of the fluoroquinolones: focus on levofloxacin. ( Liu, HH, 2010)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, HH1
Zubkov, MN1
Iakovlev, VP1
Svetukhin, AM1
Blatun, LA1
Ukhin, SA1
Guven, EO1
Balbay, D1
Kilciler, M1
Stahlmann, R1
Kohler, RB1
Arkins, N1
Tack, KJ1

Reviews

3 reviews available for ofloxacin and Central Nervous System Diseases

ArticleYear
Safety profile of the fluoroquinolones: focus on levofloxacin.
    Drug safety, 2010, May-01, Volume: 33, Issue:5

    Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Cardiovascular Diseases; Central Nervous System Dis

2010
[Efficacy and safety of levofloxacin in low respiratory tract infection].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:5

    Topics: Anti-Bacterial Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dermatitis, Atopic

2004
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:8-9

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastro

2004

Other Studies

3 other studies available for ofloxacin and Central Nervous System Diseases

ArticleYear
Unexpected, severe central nerve system toxicity of ofloxacine: report of two cases.
    International urology and nephrology, 2007, Volume: 39, Issue:2

    Topics: Aged; Anti-Infective Agents, Urinary; Central Nervous System Diseases; Female; Humans; Male; Middle

2007
Clinical toxicological aspects of fluoroquinolones.
    Toxicology letters, 2002, Feb-28, Volume: 127, Issue:1-3

    Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease

2002
Accidental overdose of intravenous ofloxacin with benign outcome.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:6

    Topics: Adult; Central Nervous System Diseases; Drug Overdose; Female; Humans; Injections, Intravenous; Oflo

1991